BioCryst Pharmaceuticals
BCRX
BCRX
98 hedge funds and large institutions have $588M invested in BioCryst Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 14 closing their positions.
Holders
98
Holders Change
+7
Holders Change %
+7.69%
% of All Funds
2.61%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
21
Increased
35
Reduced
26
Closed
14
Calls
$3.96M
Puts
$2.86M
Net Calls
+$1.11M
Net Calls Change
-$97K
Top Buyers
1 |
1
Millennium Management
New York
|
$22M |
2 |
2
Jennison Associates
New York
|
$8.79M |
3 |
3
Goldman Sachs
New York
|
$9.33M |
4 |
4
State Street
Boston,
Massachusetts
|
$30.2M |
5 |
![]()
5
Fidelity Investments
Boston,
Massachusetts
|
$98M |